Among the senior officials who will participate are Richard Francis, president and CEO of Teva; Dr. Aharon (Roni) Gal, head of strategy and growth at Novartis; Prof. Yitzhak Kreis, director of the Sheba Medical Center; Dr. Boaz Hirshberg, Senior Vice President at Regeneron; Dr. Gil Bar-Nahum, Director at the Jefferies International Investment Bank; Dror Bin, CEO of the Innovation Authority; Barry Green, CEO of Sage Therapeutics; Guy Hadari, senior vice president at Biogen; Stanley Lapidus, chairman and founder of Cytyc; Dr. Joseph Koresh, director and founder of the Institute for Optimal Aging and lecturer at the NYU School of Medicine; Dr. Avi Tzur, senior physician and head of the Center for Innovation in Women’s Health at the Sheba Medical Center and many others.
The Biomed Israel conference is the largest meeting place for healthcare professionals in Israel, who gather together for three days of intensive networking that helps drive business opportunities and promote collaborations. As in previous years, over 100 Israeli companies from the fields of life sciences, both start-ups and more established companies, will present at the conference the solutions and technologies they have developed and provide a unique opportunity for thousands of visitors who are part of the health services and health technologies community to experience the environment of innovation in the life sciences and biomedicine industries .
The conference and exhibition will deal with all areas of the life sciences, including biopharma, medical devices, digital health and diagnostic products and technologies. The event will feature a wide variety of lectures and discussion sessions that will deal with the latest trends and breakthroughs in the fields of medicine. Among other things, this year the sessions will deal with women’s health, home hospitalization, the impact of AI on the discovery of innovative drugs and clinical developments, healthy aging and the next generation of genetic medicine. Other topics that will be discussed at the conference will be innovation in the field of brain health, cardiovascular diseases, digital biomarkers, biopsy and liquid diagnostics, the medical device industry, nutrition technologies, new cancer treatments, the cardio-metabolic field, Israel’s contribution to science and technology in the industry and innovations in bio-convergence.
“This year, against the backdrop of the unrest in the region, I am especially proud of the conference we were able to organize,” said Ruthie Alon, founder and CEO of Medstrada and co-chair of the 2024 Biomed Israel conference. “The conference will include the best of what Israel has to offer in the ‘hot’ fields in the global life sciences industry. Experts will discuss a variety of topics, from new models for the treatment of diseases, through the costs of health services to turning medical data into knowledge. The conference will explore the interrelationship between trends in the health field and interventions therapeutic, both interventions for prevention and interventions for healing”.
Dr. (PhD) Ora Der, a senior expert in medical sciences and medical innovation and co-chair of the conference, stated: “Israel is a center for innovation in life sciences and medical technologies, especially in the combination of technology, artificial intelligence, machine learning and engineering together with biology, chemistry and medicine. In the last six months, the industry has shown impressive resilience in the face of challenges and uncertainty, continued to move forward, achieved achievements and created partnerships and investments.”
Dr. (MD, PhD) Nissim Darvish, CEO of the Eliraz Ventures Fund and co-chairman of the conference, added: “One of the factors that helped the health technology sector in Israel to rise and reach achievements and success is the Innovation Authority. Over the years, the Innovation Authority has provided funding for applied research, start-ups and established companies as well as created incubators and infrastructure to support industry. We thank them for their long-standing partnership and for their contribution to the success of the Biomed Israel conference.”